Connective Tissue Disease Flashcards
Diffuse Connective Tissue Diseases
- A group of chronic disorders characterized by diffuse inflammation and degeneration in the connective tissue
- Cause is unknown but thought to have an immunologic basis
- Characterized by a clinical course of exacerbations and remissions
- Includes rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), scleroderma, polymyositis, Sjogren Syndrome, polymyalgia rheumatica, and Giant Cell arteritis
SLE Systemic Effects
- Fever
- Fatigue
- Anemia
- Lymph node enlargement
- Raynaud’s phenomenon (half hand turns blue) and Sjoren Syndrome
- Any organ system may be involved; arteritis, neuropathy and other neurologic manifestations, scleritis, pericarditis, pleural effusion, splenomegaly, renal involvement
- Skin and mucosal manifestations
Systemic lupus erythematosus (SLE)
- Thought to be auto-immune…possible combination of genetic and environmental factors…
- Antinuclear Antibodies affect DNA, RNA and nucleus.
— Antinuclear Antibodies first test done to see if you have lupus - Chronic/progressive, inflammatory connective tissue disorder
- Causes major body organs and systems to fail via formed autoimmune complexes in serum and tissues which cause inflammation and damage.
- Vasculitis – Vessel inflammation deprives organs of blood and O2
- Flareups …remissions and exacerbations
- Onset acute or insidious
*Lupus Erythematosus (LE) risk factors
- Affects women 6-10 times more than men
- 3 x more in African Americans
- 20-40 years of age (child bearing age)
- Many forms besides SLE
- Discoid lupus erythematosus (skin)
- Subacute cutaneous LE
- Drug induced LE
Lupus Erythematosus (LE) (cont.)
- Main Classification:
— SLE - Systemic lupus erythematosus - Other Forms:
— DLE - Discoid lupus erythematosus (skin/ face)
— Subacute – Sun exposed areas affected with sores
— Drug Induced- rarely includes brain or kidney, Temporary
*Lupus Erythematosus (LE) Triggers
- *Sunlight - Exposure to the sun may bring on lupus skin lesions or trigger an internal response in susceptible people.
- *Infections - Having an infection can initiate lupus or cause a relapse in some people.
— stay away from sick people/ crowds
— wash hands
— take temperature - Medications - Lupus can be triggered by certain types of blood pressure medications, anti-seizure medications and antibiotics. People who have drug- induced lupus usually get better when they stop taking the medication.
— take meds
— drug induced lupus can be reversed
Assessment of Auto- Immune Disease
- Health history and physical assessment focus on:
include onset of and evolution of symptoms, family history, past health history, and contributing factors
— when did it start? - Current and past symptoms
- Patient’s psychological and mental status
- Social support systems
- *Ability to participate in daily activities or Functional Assessment
- Compliance with treatment regimen
- Management of self-care
Diagnostic Findings Chart 38-5 Criteria for Classification
- Full Assessment including all body systems
- Skin Assessment
- Laboratory:
— *Skin biopsy (only significant test to confirm diagnosis)
SLE Clinical Manifestations
- Muscles Involvement
- Polyarthritis – joint pain
- Osteonecrosis (avascular necrosis)
- Muscle atrophy
SLE Key Features
- Any organ system may be involved
- Cardiac – Myocardial fibrosis
- Musculoskeletal – Joint Inflammation
- Renal – Kidney Failure
- Pulmonary –Pulmonary HTN
- Neuro Not common
- GI – Esophagitis , Ulcers
- Other: Fever Fatigue Anorexia Vasculitis
- Lymph node enlargement
- Raynaud’s syndrome
SLE—Clinical Manifestations
- Renal involvement
— Nephritis, Kidney Failure - Pulmonary
— Pleural effusions - Cardiac
— Pericarditis, endocarditis, myocarditis
— Raynaud’s phenomenon - Neurologic manifestation
— *Fever first sign of flare up (take temperature) - Fatigue
- Anorexia
Pericarditis Assessment
- Pain
- ST elevation
- Signs of heart failure
- Assess for hx of systemic lupus erythematosus (SLE) or any systemic connective tissue disease
- Acute pericarditis is most commonly associated with acute exacerbations of systemic connective tissue disease, including SLE.
Raynaud’s Disease
Raynaud’s Disease Drug Therapy
Know signs and symptoms, adverse effects of each.
- Monoclonal antibodies – First drug approved in 60 years for SLE
— *Belimumab (Benlysta)
- allows B cells to undergo apoptosis as normal to avoid inflamation from antibody production 
— stimulate B cells to produce antibodies against the body’s own nuclei
- Corticosteroids – risk of osteoporosis and fractures
— Take meds early in the morning before breakfast when body’s natural corticosteroid level is low and reduces toxicity.
— Chronic steroid use >5 years - Osteonecrosis (avascular necrosis)
Antimalarial-
- hydroxychloroquine (Plaquenil) – anti-malarial
— check eyes
- NSAIDS/Tylenol - joint and muscle pain and inflammation.
- Immunosuppressive Agents
SLE Nursing Interventions
- Understanding the underlying disease process guides the nurse’s critical thinking to provide interventions
- Administer Medication
- Protect skin – mild soap avoid perfume, cosmetics, watch for alopecia, hair will grow back during remission.